BLC
BMY icon

Brown, Lisle/Cummings’s Bristol-Myers Squibb BMY Stock Holding History

Brown, Lisle/Cummings’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.39M Sell
22,891
-120
-0.5% -$7K 0.35% 75
2025
Q4 		$1.24M Buy
23,011
+2,113
+10% +$102K 0.31% 83
2025
Q3 		$943K Buy
20,898
+1,898
+10% +$88.6K 0.24% 99
2025
Q2 		$880K Buy
19,000
+2,262
+14% +$111K 0.23% 98
2025
Q1 		$1.02M Sell
16,738
-146
-0.9% -$8.51K 0.3% 81
2024
Q4 		$955K Sell
16,884
-6,431
-28% -$359K 0.29% 85
2024
Q3 		$1.21M Buy
23,315
+2,002
+9% +$93.9K 0.37% 71
2024
Q2 		$885K Buy
21,313
+1,413
+7% +$63.2K 0.29% 81
2024
Q1 		$1.08M Buy
19,900
+475
+2% +$24.2K 0.37% 67
2023
Q4 		$997K Buy
19,425
+1,200
+7% +$63K 0.37% 66
2023
Q3 		$1.06M Sell
18,225
-2,727
-13% -$167K 0.48% 54
2023
Q2 		$1.34M Sell
20,952
-3,823
-15% -$256K 0.6% 43
2023
Q1 		$1.72M Sell
24,775
-125
-0.5% -$8.82K 0.87% 29
2022
Q4 		$1.79M Buy
24,900
+764
+3% +$57.6K 0.96% 30
2022
Q3 		$1.72M Sell
24,136
-150
-0.6% -$10.9K 1% 24
2022
Q2 		$1.87M Sell
24,286
-1,595
-6% -$121K 1.03% 24
2022
Q1 		$1.89M Buy
25,881
+3,600
+16% +$242K 0.91% 27
2021
Q4 		$1.39M Buy
+22,281
New +$1.31M 0.69% 35

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brown, Lisle/Cummings's BMY Position: Q1 2026 in Review

Brown, Lisle/Cummings reduced its Bristol-Myers Squibb (BMY) stake by 0.52% in Q1 2026, selling an estimated $7K and leaving 22,891 shares worth $1.39M. The position accounts for 0.35% of the portfolio, ranked #75.

Brown, Lisle/Cummings first reported a position in BMY in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.89M in Q1 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Brown, Lisle/Cummings held 22,891 shares of Bristol-Myers Squibb worth $1.39M as of Q1 2026.
  • Brown, Lisle/Cummings sold 120 Bristol-Myers Squibb shares in Q1 2026, an estimated $7K.
  • Bristol-Myers Squibb made up 0.35% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #75 holding.
  • Brown, Lisle/Cummings first reported a position in Bristol-Myers Squibb in Q4 2021 and has held it in 18 quarters since.
  • Brown, Lisle/Cummings's Bristol-Myers Squibb position peaked at $1.89M in Q1 2022.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.